Does hyperbaric oxygen therapy work? What the trials actually tested
The trial evidence for hyperbaric oxygen therapy sits in wounds that will not heal. The ageing and brain claims rest on reviews, not randomised trials.
Educational, not medical advice. Always consult a qualified healthcare provider before changing your diet, supplements, or routine. Full disclaimer.
Recommendation
Hyperbaric oxygen therapy has randomised trial evidence behind one use, and it is not the one longevity clinics advertise: helping foot ulcers heal in people with diabetes. Pooled results from 20 randomised trials covering 1,263 patients found those ulcers healed nearly twice as often and led to roughly half as many major amputations when the therapy was added to standard care [1]. The claims about slower ageing and sharper thinking come from review articles and small studies [7][8][15], not from trials of that size, and the reviews themselves say so.
The findings
Hyperbaric oxygen therapy works best where there is a wound that will not heal. Hyperbaric oxygen therapy means breathing pure oxygen inside a sealed chamber pressurised above normal air pressure, and the randomised trials behind it sit almost entirely in one condition: foot ulcers in people with diabetes [1][2][5].
In medicine it is not new. A 1994 review listed 12 conditions for which the therapy may be beneficial [6], and later reviews list carbon monoxide poisoning, smoke inhalation, wounds caused by radiation treatment and decompression illness - the injury divers get from surfacing too fast - among the established uses [8][11].
A pooled analysis of 20 randomised trials covering 1,263 patients found diabetic foot ulcers healed nearly twice as often with the therapy added to standard care, healed about 19 days sooner, and led to roughly half as many major amputations - the operations that take part of the foot or leg rather than a toe [1]. A second pooled analysis, 14 studies and 768 participants, found about 40% fewer major amputations, but no difference in the smaller amputations, in how much the ulcer shrank, or in how many patients died [2].
The meta-analyses do not agree with each other. An earlier pooling of 9 randomised trials in 526 patients found no difference at all in how many ulcers healed or in amputations of either size; the only thing that moved was the wound area, which shrank more [5]. The same question, put to three sets of trials, comes back with different answers.
For athletes the answer splits in two. A 2026 pooling of 10 randomised trials in 299 people found the therapy sped up recovery from exercise-induced muscle injury but did nothing for muscle soreness [4]. Sessions in those trials ran 60 or 100 minutes, at pressures both above and below two atmospheres absolute [4]. Two atmospheres absolute is double the air pressure at sea level, roughly what you would feel 10 metres underwater.
What longevity clinics lean on is a weaker kind of evidence. A review of hyperbaric oxygen and healthy ageing describes laboratory work and small-scale clinical investigations rather than large trials, and says a usable protocol for treating ageing still has to be defined [7]. A review on cognition describes the therapy being used after brain injury and stroke, and in mild cognitive impairment, as a developing application [8]. A third review lists effects on gene expression, cell senescence and telomere length - telomeres being the protective caps on the ends of chromosomes, which shorten as cells divide - under future prospects, not results [15].
Why it works
Pressure is what makes the oxygen go further. Breathing pure oxygen under pressure raises the amount dissolved in the blood plasma - the liquid part of blood, as opposed to the oxygen carried by red blood cells - by five to twenty times [9]. That surplus reaches tissue a poor blood supply has left starved, which is the honest reason the wound trials are the ones that worked [1][11].
That oxygen lands on the mitochondria. Mitochondria are the parts of the cell that burn oxygen to make energy, and they are also where reactive oxygen species are produced - unstable molecules that damage cell parts when there are too many of them [9]. Short courses of the therapy have been shown to worsen mitochondrial activity and push those damaging molecules up, while long courses improve mitochondrial activity and bring them down, partly by strengthening the cell's own defences [9]. The number of sessions is not a scheduling detail. It changes the direction of the effect.
A review of surgical use describes the therapy switching on the growth of new blood vessels through oxygen-sensitive signalling proteins, speeding up the cells that lay down collagen - the structural protein that holds healing tissue together - and mobilising a type of immature repair cell that circulates in the blood [11]. Reviews of brain applications point at overlapping processes: the growth of new nerve cells and of new connections between them, alongside lower levels of inflammatory signalling molecules [12]. Those are descriptions of what happens in cells, and they are not the same thing as a measured outcome in a person.
Limitations
The people in these trials are not the people who book a session at a wellness clinic. The wound evidence comes from patients with diabetes whose foot ulcers had not healed [1][2][5], and the muscle evidence from college students and elite athletes whose muscle damage was deliberately induced [4]. Neither group tells you what a chamber does for a healthy adult.
The pooled analyses also contradict one another, which is what happens when the underlying trials are small and run to different protocols. Two found faster healing and fewer amputations [1][2]; a third found none of it [5]. The one analysis that counted deaths found no difference between the groups [2].
The ageing and cognition material is a different class of evidence altogether:
- the healthy-ageing paper is a review that summarises mechanisms and small studies, and states that a protocol for treating ageing still needs defining [7]
- the cognition paper is a review of mechanisms and applications rather than a trial [8]
- the regenerative paper files senescence and telomere effects under prospects [15]
- a review of surgical use reports that the trials that do exist use different pressures and different schedules, which is part of why the therapy has not spread [11]
Serious complications are uncommon, at fewer than 0.5% of treatments in that surgical review [11], but a safety figure is not evidence that the therapy does what a clinic says it will. None of these papers tested the low-pressure inflatable chambers sold for home use, and none followed anyone long enough to say anything about lifespan.
Real-world example
Longevity clinics list hyperbaric oxygen among their services, and the chamber time is the easy part to picture: in the exercise-recovery trials a session ran 60 or 100 minutes at pressures around two atmospheres absolute, double the air pressure at sea level [4]. The harder part is what to expect from it, and that depends on why you are going. The strongest evidence was collected in people whose wounds would not close, over a course of sessions, as an addition to standard medical care [1][2] - not in healthy adults buying an hour. Anyone weighing it up against a specific medical condition is weighing a treatment decision, which is one to take with a doctor who knows the case.
Primary paper
Efficacy of hyperbaric oxygen therapy for diabetic foot ulcers: An updated systematic review and meta-analysis.
Zhang Z, et al.
Asian journal of surgery, 2022
View paper on publisher websiteSources
Numbers in brackets [1], [2]… in the body link to this list.
- [1]
Efficacy of hyperbaric oxygen therapy for diabetic foot ulcers: An updated systematic review and meta-analysis.
Zhang Z, Zhang W, Xu Y, et al. · Asian journal of surgery · 2022
doi.org/10.1016/j.asjsur.2021.07.047 - [2]
Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials.
Sharma R, Sharma SK, Mudgal SK, et al. · Scientific reports · 2021
doi.org/10.1038/s41598-021-81886-1 - [3]
Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
Chu DK, Kim LH, Young PJ, et al. · Lancet (London, England) · 2018
doi.org/10.1016/S0140-6736(18)30479-3 - [4]
Effects of Hyperbaric Oxygen Therapy on Exercise-Induced Muscle Injury and Soreness: A Systematic Review and Meta-analysis.
Luo X, Yu Y, Zhang S, et al. · Archives of physical medicine and rehabilitation · 2026
doi.org/10.1016/j.apmr.2025.07.017 - [5]
Efficacy and Safety of Hyperbaric Oxygen Therapy Used in Patients With Diabetic Foot: A Meta-analysis of Randomized Clinical Trials.
Zhao D, Luo S, Xu W, et al. · Clinical therapeutics · 2017
doi.org/10.1016/j.clinthera.2017.08.014 - [6]
- [7]
Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics.
Fu Q, Duan R, Sun Y, et al. · Redox biology · 2022
doi.org/10.1016/j.redox.2022.102352 - [8]
Hyperbaric Oxygen Treatment-From Mechanisms to Cognitive Improvement.
Gottfried I, Schottlender N, Ashery U · Biomolecules · 2021
doi.org/10.3390/biom11101520 - [9]
Hyperbaric Oxygen Treatment: Effects on Mitochondrial Function and Oxidative Stress.
Schottlender N, Gottfried I, Ashery U · Biomolecules · 2021
doi.org/10.3390/biom11121827 - [10]
Retinitis Pigmentosa: From Pathomolecular Mechanisms to Therapeutic Strategies.
Vingolo EM, Mascolo S, Miccichè F, et al. · Medicina (Kaunas, Lithuania) · 2024
doi.org/10.3390/medicina60010189 - [11]
Perioperative hyperbaric oxygen therapy: mechanisms, evidence, and clinical application.
Gavaza T, Matei N · Medical gas research · 2027
doi.org/10.4103/mgr.MEDGASRES-D-25-00318 - [12]
Hyperbaric oxygen therapy as a neuromodulatory technique: a review of the recent evidence.
Bin-Alamer O, Abou-Al-Shaar H, Efrati S, et al. · Frontiers in neurology · 2024
doi.org/10.3389/fneur.2024.1450134 - [13]
Global vascular guidelines on the management of chronic limb-threatening ischemia.
Conte MS, Bradbury AW, Kolh P, et al. · Journal of vascular surgery · 2019
doi.org/10.1016/j.jvs.2019.02.016 - [14]
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.
Conte MS, Bradbury AW, Kolh P, et al. · European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2019
doi.org/10.1016/j.ejvs.2019.05.006 - [15]
Hyperbaric oxygen therapy: future prospects in regenerative therapy and anti-aging.
Gupta M, Rathored J · Frontiers in aging · 2024
doi.org/10.3389/fragi.2024.1368982